| . | Pain . | No pain . | p . | Adjusted p . |
|---|---|---|---|---|
| N | 151 [75.5%] | 49 [24.5%] | ||
| Age | 42.9 [19–78] | 49.7 [19–87] | 0.019 | 0.04 |
| Sex male [%] | 61 [40.4%] | 32 [65.3%] | 0.002 | 0.005 |
| Weight [kg] | 70.3 ± 15.3 | 77 ± 14 | 0.002 | 0.005 |
| Height [cm] | 170 ± 9 | 173 ± 9 | 0.046 | 0.085 |
| BMI [kg/m2] | 23.4 [20.9–26.5] | 26.1 [23.4–28.1] | 0.002 | 0.005 |
| Smoking | 40 [26.5] | 8 [16.3] | 0.15 | 0.225 |
| Alcohol > 10 U/week | 16 [10.6] | 10 [20.4] | 0.076 | 0.127 |
| Crohn’s/ulcerative colitis: | 112 [74.2%]/39 [25.8%] | 22 [44.9]/27 [55.1%] | <0.001 | 0.003 |
| Duration of IBD | 13 [7–21] | 16 [8–24] | 0.24 | 0.31 |
| Corticosteroids | 33 [21.9%] | 10 [20.4%] | 0.83 | 0.89 |
| Anti-TNFα or immunomodulators | 126 [83.4%] | 38 [77.6%] | 0.35 | 0.43 |
| Abdominal pain | 124 [82.1%] | 0 | NA | |
| Extra-intestinal pain | 85 [56.2%] | 0 | NA | |
| Surgery for IBD | 45 [29.8%] | 7 [14.3%] | 0.03 | 0.05 |
| . | Pain . | No pain . | p . | Adjusted p . |
|---|---|---|---|---|
| N | 151 [75.5%] | 49 [24.5%] | ||
| Age | 42.9 [19–78] | 49.7 [19–87] | 0.019 | 0.04 |
| Sex male [%] | 61 [40.4%] | 32 [65.3%] | 0.002 | 0.005 |
| Weight [kg] | 70.3 ± 15.3 | 77 ± 14 | 0.002 | 0.005 |
| Height [cm] | 170 ± 9 | 173 ± 9 | 0.046 | 0.085 |
| BMI [kg/m2] | 23.4 [20.9–26.5] | 26.1 [23.4–28.1] | 0.002 | 0.005 |
| Smoking | 40 [26.5] | 8 [16.3] | 0.15 | 0.225 |
| Alcohol > 10 U/week | 16 [10.6] | 10 [20.4] | 0.076 | 0.127 |
| Crohn’s/ulcerative colitis: | 112 [74.2%]/39 [25.8%] | 22 [44.9]/27 [55.1%] | <0.001 | 0.003 |
| Duration of IBD | 13 [7–21] | 16 [8–24] | 0.24 | 0.31 |
| Corticosteroids | 33 [21.9%] | 10 [20.4%] | 0.83 | 0.89 |
| Anti-TNFα or immunomodulators | 126 [83.4%] | 38 [77.6%] | 0.35 | 0.43 |
| Abdominal pain | 124 [82.1%] | 0 | NA | |
| Extra-intestinal pain | 85 [56.2%] | 0 | NA | |
| Surgery for IBD | 45 [29.8%] | 7 [14.3%] | 0.03 | 0.05 |
Data are mean [range] for age, number [%], mean ± SD or median [IQR]. IBD = inflammatory bowel disease; BMI = body mass index; TNF = tumour necrosis factor. Active disease was defined as Harvey–Bradshaw Index16 >4 for CD patients and partial Mayo score19 >2 for UC patients. Adj. p: adjusted p values using the method of Benjamini and Hochberg.
| . | Pain . | No pain . | p . | Adjusted p . |
|---|---|---|---|---|
| N | 151 [75.5%] | 49 [24.5%] | ||
| Age | 42.9 [19–78] | 49.7 [19–87] | 0.019 | 0.04 |
| Sex male [%] | 61 [40.4%] | 32 [65.3%] | 0.002 | 0.005 |
| Weight [kg] | 70.3 ± 15.3 | 77 ± 14 | 0.002 | 0.005 |
| Height [cm] | 170 ± 9 | 173 ± 9 | 0.046 | 0.085 |
| BMI [kg/m2] | 23.4 [20.9–26.5] | 26.1 [23.4–28.1] | 0.002 | 0.005 |
| Smoking | 40 [26.5] | 8 [16.3] | 0.15 | 0.225 |
| Alcohol > 10 U/week | 16 [10.6] | 10 [20.4] | 0.076 | 0.127 |
| Crohn’s/ulcerative colitis: | 112 [74.2%]/39 [25.8%] | 22 [44.9]/27 [55.1%] | <0.001 | 0.003 |
| Duration of IBD | 13 [7–21] | 16 [8–24] | 0.24 | 0.31 |
| Corticosteroids | 33 [21.9%] | 10 [20.4%] | 0.83 | 0.89 |
| Anti-TNFα or immunomodulators | 126 [83.4%] | 38 [77.6%] | 0.35 | 0.43 |
| Abdominal pain | 124 [82.1%] | 0 | NA | |
| Extra-intestinal pain | 85 [56.2%] | 0 | NA | |
| Surgery for IBD | 45 [29.8%] | 7 [14.3%] | 0.03 | 0.05 |
| . | Pain . | No pain . | p . | Adjusted p . |
|---|---|---|---|---|
| N | 151 [75.5%] | 49 [24.5%] | ||
| Age | 42.9 [19–78] | 49.7 [19–87] | 0.019 | 0.04 |
| Sex male [%] | 61 [40.4%] | 32 [65.3%] | 0.002 | 0.005 |
| Weight [kg] | 70.3 ± 15.3 | 77 ± 14 | 0.002 | 0.005 |
| Height [cm] | 170 ± 9 | 173 ± 9 | 0.046 | 0.085 |
| BMI [kg/m2] | 23.4 [20.9–26.5] | 26.1 [23.4–28.1] | 0.002 | 0.005 |
| Smoking | 40 [26.5] | 8 [16.3] | 0.15 | 0.225 |
| Alcohol > 10 U/week | 16 [10.6] | 10 [20.4] | 0.076 | 0.127 |
| Crohn’s/ulcerative colitis: | 112 [74.2%]/39 [25.8%] | 22 [44.9]/27 [55.1%] | <0.001 | 0.003 |
| Duration of IBD | 13 [7–21] | 16 [8–24] | 0.24 | 0.31 |
| Corticosteroids | 33 [21.9%] | 10 [20.4%] | 0.83 | 0.89 |
| Anti-TNFα or immunomodulators | 126 [83.4%] | 38 [77.6%] | 0.35 | 0.43 |
| Abdominal pain | 124 [82.1%] | 0 | NA | |
| Extra-intestinal pain | 85 [56.2%] | 0 | NA | |
| Surgery for IBD | 45 [29.8%] | 7 [14.3%] | 0.03 | 0.05 |
Data are mean [range] for age, number [%], mean ± SD or median [IQR]. IBD = inflammatory bowel disease; BMI = body mass index; TNF = tumour necrosis factor. Active disease was defined as Harvey–Bradshaw Index16 >4 for CD patients and partial Mayo score19 >2 for UC patients. Adj. p: adjusted p values using the method of Benjamini and Hochberg.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
